AUS
NZ
UK
CA
USA
IND
Highlights:
- Kneat.com signs a three-year Master Services Agreement with a prominent global pharmaceutical company.
- The partnership aims to streamline validation processes, starting with Computer System Validation (CSV).
- Kneat’s digital validation platform promises significant reductions in validation cycle times and increased compliance.
Kneat.com, Inc. (TSX:KSI) (OTC:KSIOF), a leading provider of digitized validation and quality processes, has announced a significant milestone: a three-year Master Services Agreement with a major global pharmaceutical company. This agreement marks a pivotal step in the pharmaceutical sector's ongoing transition to digital solutions, aiming to enhance the efficiency, accuracy, and compliance of validation processes across the company's global operations.
The global pharmaceutical company, headquartered in Germany and employing over 11,000 individuals across more than a dozen facilities, is well-regarded for its household consumer health care brands, as well as generic and specialty pharmaceuticals. With a reach extending to over 120 countries, the company has established itself as a trusted manufacturer. After a thorough evaluation of potential solutions, it selected Kneat as its corporate partner to streamline and digitize its complex validation processes, starting specifically with Computer System Validation (CSV).
Kneat’s CEO, Eddie Ryan, expressed enthusiasm about the partnership, stating, “This announcement further demonstrates Kneat’s leadership position across the full Validation spectrum. We look forward to supporting this company to achieve harmonization for all their validation processes on a single platform.” This sentiment highlights Kneat's commitment to facilitating smoother, more efficient operations for its partners, positioning itself as a vital ally in the digital transformation of validation processes.
The focus on Computer System Validation is particularly relevant in today’s highly regulated environments. As companies like Kneat address the intricate and often cumbersome processes associated with validation, they provide tools that enhance not only compliance but also operational agility.
Kneat Solutions provides a state-of-the-art digital validation platform known as Kneat Gx. This platform is designed to meet the unique needs of highly regulated industries, delivering unparalleled efficiency in validation and compliance. Kneat Gx is fully ISO 9001 and ISO 27001 certified, validated, and compliant with 21 CFR Part 11 and Annex 11 regulations.
According to multiple independent customer studies, companies utilizing Kneat Gx have experienced remarkable results, including a reduction of validation cycle times by 40% or more, nearly 20% faster speed to market, and an 80% decrease in changeover time. These outcomes are not just metrics; they reflect the platform's transformative potential, allowing organizations to allocate resources more effectively while adhering to stringent regulatory standards.
As Kneat.com embarks on this new collaboration, the pharmaceutical industry can expect to see a significant evolution in how validation processes are managed. The digitization of these processes not only enhances operational efficiency but also fosters an environment of compliance and accountability.
